Research Article

Mannose-Binding Lectin Promoter Polymorphisms and Gene Variants in Pulmonary Tuberculosis Patients from Cantabria (Northern Spain)

Table 3

Frequencies of complete diplotypes in Spanish PTB patients and controls.

MBL2 diplotypes*PTB patients
(%)
Controls
(%)
valueOR(95% CI)

LYQA/HYPA17 (15.9)54 (12.24)0.401.35(0.75–2.45)
LYQA/LYPB10 (9.3)29 (6.58)0.431.46(0.69–3.11)
LYQA/LYPA6 (5.6)19 (4.31)0.601.32(0.51–3.39)
LYQA/LYQA3 (2.8)19 (4.31)0.590.64(0.19–2.20)
LYQA/HYPD1 (0.9)10 (2.27)0.700.41(0.05–3.21)
LYQA/LYQC0 (0)2 (0.45)1.0NANA
LYQC/HYPD0 (0)1 (0.23)1.0NANA
LXPA/HYPA15 (14.0)45 (10.20)0.341.43(0.77–2.69)
LXPA/LYQA10 (9.3)53 (12.02)0.540.75(0.37–1.54)
LXPA/LXPA7 (6.5)14 (3.17)0.152.14(0.84–5.43)
LXPA/LYPB4 (3.7)31 (7.03)0.300.51(0.18–1.49)
LXPA/HYPD3 (2.8)13 (2.95)1.00.95(0.27–3.39)
LXPA/LYPA1 (0.9)10 (2.27)0.700.41(0.05–3.21)
LXPA/LYQC1 (0.9)2 (0.45)0.482.07(0.19–23.05)
HYPA/HYPA10 (9.3)38 (8.62)0.961.09(0.53–2.27)
LYPB/HYPA8 (7.5)38 (8.62)0.880.86(0.39–1.89)
LYPB/LYPB1 (0.9)7 (1.59)1.00.58(0.07–4.81)
LYPB/LYQC1 (0.9)1 (0.23)0.354.15(0.26–66.90)
LYPB/HYPD0 (0)9 (2.04)0.22NANA
LYPA/HYPA4 (3.7)18 (4.08)1.00.91(1.30–2.75)
LYPA/LYPB3 (2.8)4 (0.91)0.143.15(0.69–14.30)
LYPA/LYPA1 (0.9)2 (0.45)0.482.07(0.19–23.05)
LYPA/LYQC0 (0)1 (0.23)1.0NANA
LYPA/HYPD1 (0.9)2 (0.45)0.482.07(0.19–23.05)
HYPD/HYPA0 (0)14 (3.17)0.08NANA
HYPD/HYPD0 (0)5 (1.13)0.59NANA

*Frequencies of the rest of combined diplotypes (LYQC/HYPA, LYQC/LYQC) were 0 in both groups.